Oxytocin Side Effects: What Studies and Users Report
What FDA labels, clinical studies and people who use Oxytocin report, how strong that evidence is, and what is still unknown.
Side effects reported in studies
Adverse reactions from the FDA label come first, then side effects reported in individual studies. Frequencies are quoted as the source gives them; animal results are labelled.
| Side effect | How common | Study type | Source |
|---|---|---|---|
| Water intoxication“Severe water intoxication with convulsions and coma has occurred, associated with a slow oxytocin infusion over a 24-hour period.” | Frequency not stated | FDA label | FDA label (Pitocin) |
| Uterine hypertonicity or rupture“Excessive dosage or hypersensitivity to the drug may result in uterine hypertonicity, spasm, tetanic contraction, or rupture of the uterus.” | Frequency not stated | FDA label | FDA label (Pitocin) |
| Anaphylactic reaction (mother)“The following adverse reactions have been reported in the mother: Anaphylactic reaction Premature ventricular contractions Postpartum hemorrhage Pelvic hematoma Cardiac arrhythmia Subarachnoid hemorrhage Fatal afibrinogenemia Hypertensive episodes Nausea Rupture of the uterus Vomiting” | Frequency not stated | FDA label | FDA label (Pitocin) |
| Premature ventricular contractions (mother)“The following adverse reactions have been reported in the mother: Anaphylactic reaction Premature ventricular contractions Postpartum hemorrhage Pelvic hematoma Cardiac arrhythmia Subarachnoid hemorrhage Fatal afibrinogenemia Hypertensive episodes Nausea Rupture of the uterus Vomiting” | Frequency not stated | FDA label | FDA label (Pitocin) |
| Postpartum haemorrhage (mother)“The following adverse reactions have been reported in the mother: Anaphylactic reaction Premature ventricular contractions Postpartum hemorrhage Pelvic hematoma Cardiac arrhythmia Subarachnoid hemorrhage Fatal afibrinogenemia Hypertensive episodes Nausea Rupture of the uterus Vomiting” | Frequency not stated | FDA label | FDA label (Pitocin) |
| Pelvic haematoma (mother)“The following adverse reactions have been reported in the mother: Anaphylactic reaction Premature ventricular contractions Postpartum hemorrhage Pelvic hematoma Cardiac arrhythmia Subarachnoid hemorrhage Fatal afibrinogenemia Hypertensive episodes Nausea Rupture of the uterus Vomiting” | Frequency not stated | FDA label | FDA label (Pitocin) |
| Cardiac arrhythmia (mother)“The following adverse reactions have been reported in the mother: Anaphylactic reaction Premature ventricular contractions Postpartum hemorrhage Pelvic hematoma Cardiac arrhythmia Subarachnoid hemorrhage Fatal afibrinogenemia Hypertensive episodes Nausea Rupture of the uterus Vomiting” | Frequency not stated | FDA label | FDA label (Pitocin) |
| Subarachnoid haemorrhage (mother)“The following adverse reactions have been reported in the mother: Anaphylactic reaction Premature ventricular contractions Postpartum hemorrhage Pelvic hematoma Cardiac arrhythmia Subarachnoid hemorrhage Fatal afibrinogenemia Hypertensive episodes Nausea Rupture of the uterus Vomiting” | Frequency not stated | FDA label | FDA label (Pitocin) |
| Fatal afibrinogenemia (mother)“The following adverse reactions have been reported in the mother: Anaphylactic reaction Premature ventricular contractions Postpartum hemorrhage Pelvic hematoma Cardiac arrhythmia Subarachnoid hemorrhage Fatal afibrinogenemia Hypertensive episodes Nausea Rupture of the uterus Vomiting” | Frequency not stated | FDA label | FDA label (Pitocin) |
| Hypertensive episodes (mother)“The following adverse reactions have been reported in the mother: Anaphylactic reaction Premature ventricular contractions Postpartum hemorrhage Pelvic hematoma Cardiac arrhythmia Subarachnoid hemorrhage Fatal afibrinogenemia Hypertensive episodes Nausea Rupture of the uterus Vomiting” | Frequency not stated | FDA label | FDA label (Pitocin) |
| Nausea (mother)“The following adverse reactions have been reported in the mother: Anaphylactic reaction Premature ventricular contractions Postpartum hemorrhage Pelvic hematoma Cardiac arrhythmia Subarachnoid hemorrhage Fatal afibrinogenemia Hypertensive episodes Nausea Rupture of the uterus Vomiting” | Frequency not stated | FDA label | FDA label (Pitocin) |
| Vomiting (mother)“The following adverse reactions have been reported in the mother: Anaphylactic reaction Premature ventricular contractions Postpartum hemorrhage Pelvic hematoma Cardiac arrhythmia Subarachnoid hemorrhage Fatal afibrinogenemia Hypertensive episodes Nausea Rupture of the uterus Vomiting” | Frequency not stated | FDA label | FDA label (Pitocin) |
| Maternal death from water intoxication“Maternal death due to oxytocin-induced water intoxication has been reported.” | Frequency not stated | FDA label | FDA label (Pitocin) |
| Bradycardia (fetus or neonate)“The following adverse reactions have been reported in the fetus or neonate: Due to induced uterine motility: Due to use of oxytocin in the mother: Bradycardia Low Apgar scores at five minutes Premature ventricular contractions and other arrhythmias Neonatal jaundice Permanent CNS or brain damage Neonatal retinal hemorrhage Fetal death” | Frequency not stated | FDA label | FDA label (Pitocin) |
| Low Apgar scores at five minutes (fetus or neonate)“The following adverse reactions have been reported in the fetus or neonate: Due to induced uterine motility: Due to use of oxytocin in the mother: Bradycardia Low Apgar scores at five minutes Premature ventricular contractions and other arrhythmias Neonatal jaundice Permanent CNS or brain damage Neonatal retinal hemorrhage Fetal death” | Frequency not stated | FDA label | FDA label (Pitocin) |
| Neonatal jaundice (fetus or neonate)“The following adverse reactions have been reported in the fetus or neonate: Due to induced uterine motility: Due to use of oxytocin in the mother: Bradycardia Low Apgar scores at five minutes Premature ventricular contractions and other arrhythmias Neonatal jaundice Permanent CNS or brain damage Neonatal retinal hemorrhage Fetal death” | Frequency not stated | FDA label | FDA label (Pitocin) |
| Permanent CNS or brain damage (fetus or neonate)“The following adverse reactions have been reported in the fetus or neonate: Due to induced uterine motility: Due to use of oxytocin in the mother: Bradycardia Low Apgar scores at five minutes Premature ventricular contractions and other arrhythmias Neonatal jaundice Permanent CNS or brain damage Neonatal retinal hemorrhage Fetal death” | Frequency not stated | FDA label | FDA label (Pitocin) |
| Neonatal retinal haemorrhage (fetus or neonate)“The following adverse reactions have been reported in the fetus or neonate: Due to induced uterine motility: Due to use of oxytocin in the mother: Bradycardia Low Apgar scores at five minutes Premature ventricular contractions and other arrhythmias Neonatal jaundice Permanent CNS or brain damage Neonatal retinal hemorrhage Fetal death” | Frequency not stated | FDA label | FDA label (Pitocin) |
| Fetal death (fetus or neonate)“The following adverse reactions have been reported in the fetus or neonate: Due to induced uterine motility: Due to use of oxytocin in the mother: Bradycardia Low Apgar scores at five minutes Premature ventricular contractions and other arrhythmias Neonatal jaundice Permanent CNS or brain damage Neonatal retinal hemorrhage Fetal death” | Frequency not stated | FDA label | FDA label (Pitocin) |
| Neonatal seizures“Neonatal seizures have been reported with the use of Pitocin.” | Frequency not stated | FDA label | FDA label (Pitocin) |
| Headache | 1 of 15 on oxytocin every day; 2 of 55 every third day; 2 on placebo | Human RCTn = 94 | The Lancet. Neurology 2025, PMID 39862881 |
| Upper respiratory tract infection | 5 of 78 on placebo; 3 (5%) on every-third-day oxytocin | Human RCTn = 94 | The Lancet. Neurology 2025, PMID 39862881 |
| Nasal discomfort | 6 of 31 on oxytocin; 2 of 30 on placebo | Human RCTn = 61 | ClinicalTrials.gov NCT03043053 |
| Headache | 5 of 31 on oxytocin; 7 of 30 on placebo | Human RCTn = 61 | ClinicalTrials.gov NCT03043053 |
| Blood glucose increased | 4 of 31 on oxytocin; 3 of 30 on placebo | Human RCTn = 61 | ClinicalTrials.gov NCT03043053 |
| Nasal congestion | 1 of 31 on oxytocin; 2 of 30 on placebo | Human RCTn = 61 | ClinicalTrials.gov NCT03043053 |
| Nausea | 1 of 31 on oxytocin; 2 of 30 on placebo | Human RCTn = 61 | ClinicalTrials.gov NCT03043053 |
| Increased Appetite | 23 of 146 on oxytocin (double-blind phase); 14 of 144 on placebo (double-blind phase) | Human RCTn = 290 | ClinicalTrials.gov NCT01944046 |
| Sedation | 19 of 146 on oxytocin (double-blind phase); 12 of 144 on placebo (double-blind phase) | Human RCTn = 290 | ClinicalTrials.gov NCT01944046 |
| Cough | 26 of 146 on oxytocin (double-blind phase); 18 of 144 on placebo (double-blind phase) | Human RCTn = 290 | ClinicalTrials.gov NCT01944046 |
| Aggression Or Hostility | 23 of 146 on oxytocin (double-blind phase); 20 of 144 on placebo (double-blind phase) | Human RCTn = 290 | ClinicalTrials.gov NCT01944046 |
| Headache | 11 of 146 on oxytocin (double-blind phase); 22 of 144 on placebo (double-blind phase) | Human RCTn = 290 | ClinicalTrials.gov NCT01944046 |
| Seizures (serious adverse event) | 1 of 127 on oxytocin (open-label phase) | Human RCTn = 290 | ClinicalTrials.gov NCT01944046 |
| Nausea (IV oxytocin at caesarean; less with initial bolus under 5 IU) | risk ratio 0.26 for initial bolus <5 IU vs 5-9 IU | Meta-analysisn = 7333 | American journal of obstetrics and gynecology 2021, PMID 33957113 |
| Nasal discomfort | 14.3% | Meta-analysisn = 223 | Psychiatry and clinical neurosciences 2018, PMID 29232031 |
| Tiredness | 7.2% | Meta-analysisn = 223 | Psychiatry and clinical neurosciences 2018, PMID 29232031 |
| Irritability | 9.0% | Meta-analysisn = 223 | Psychiatry and clinical neurosciences 2018, PMID 29232031 |
| Diarrhoea | 4.5% | Meta-analysisn = 223 | Psychiatry and clinical neurosciences 2018, PMID 29232031 |
| Skin irritation | 4.5% | Meta-analysisn = 223 | Psychiatry and clinical neurosciences 2018, PMID 29232031 |
| Aggression (severe adverse event) | 2 on oxytocin, 1 on placebo | Meta-analysisn = 223 | Psychiatry and clinical neurosciences 2018, PMID 29232031 |
Showing the first 40 of 41 rows, strongest sources first.
Overall safety findings
What studies said about safety as a whole, without naming a specific effect.
| Finding | How common | Study type | Source |
|---|---|---|---|
| Vasopressin (water balance) safety marker“Chronic IN OXT administration did not alter AVP levels, supporting safety of OXT-based therapeutics.” | Frequency not stated | Human RCTn = 61 | The Journal of clinical endocrinology and metabolism 2025, PMID 40314146 |
| Adverse events similar to placebo“The incidence and severity of adverse events were similar in the two groups.” | Frequency not stated | Human RCTn = 290 | The New England journal of medicine 2021, PMID 34644471 |
| Tolerability“Oxytocin administration was well tolerated without any significant adverse events.” | Frequency not stated | Human RCTn = 21 | Journal of the American Medical Directors Association 2021, PMID 34029521 |
| Restlessness | more often than placebo | Systematic review | Journal of child and adolescent psychopharmacology 2014, PMID 24679173 |
| Increased irritability | more often than placebo | Systematic review | Journal of child and adolescent psychopharmacology 2014, PMID 24679173 |
| Increased energy | more often than placebo | Systematic review | Journal of child and adolescent psychopharmacology 2014, PMID 24679173 |
What users report
Side effects people describe from their own use of Oxytocin, quoted from 23 Reddit threads we read in r/Peptides and r/PeptideGuide (searched 11 Oct 2026). Each count is the number of different people in those threads, not how common the effect is. These reports are unverified: products bought outside a pharmacy are often mislabelled or impure, and many people take several compounds at once.
| What people noticed | People reporting it | In their words |
|---|---|---|
| Flushing or head rush after injection | 19 | “I do get the head pressure and the flushing pretty quickly afterwards for a couple of minutes.” r/Peptides, Jul 2026“I tried 100 mcg subq and thought I was going to die , my heart was racing so fast and the head rush I got was so intense I couldn’t stand” r/Peptides, Jul 2026 |
| Headache | 7 | “Oxytocin gives me a massive headache” r/Peptides, Mar 2025“Gives me a nasty heat sensation in my ears and then a headache ensues” r/Peptides, Mar 2025 |
| Racing heart | 4 | “Instant headache and racing heart.” r/Peptides, Jul 2026“my heart was racing so fast” r/Peptides, Jul 2026 |
| Stomach cramps or upset stomach | 3 | “Gave me the worst stomach cramps and i took a small dose.” r/Peptides, May 2026“hot sweaty flushes and cramps” r/Peptides, Aug 2024 |
| Diarrhea | 1 | “It also makes me shit like crazy lol.” r/Peptides, Mar 2025 |
| Tiredness or lethargy | 1 | “I think it makes me just feel out of it and kind of lethargic lol.” r/Peptides, Mar 2025 |
| Low mood | 1 | “Made me super depressed mood a day or 2 after I took it.” r/Peptides, Mar 2025 |
| Anxiety or jitteriness | 1 | “if I took too much, I could feel a little anxious but that passed really quickly” r/Peptides, Jun 2024 |
| Metallic taste | 1 | “I get that metallic taste in my mouth (dysgeusia).” r/Peptides, Jan 2026 |
A symptom others mention is not proof that it is harmless. If you have anything on the urgent list below, get care whatever others report.
What is not known
- How common each effect is at the doses people use outside of studies.
- Effects that take longer to appear than the length of the published studies.
- How Oxytocin interacts with other medicines and supplements.
- Whether research-grade products, which are not checked by the FDA, behave like the material used in studies.
When to get medical help
This is not a complete list. A doctor or pharmacist can help you judge whether a symptom is related.
What the Pitocin label flags
The label ties water intoxication with convulsions to oxytocin's inherent antidiuretic effect when large doses are infused for long periods.[1]
Overdosage is described as uterine hyperactivity that can lead to uterine rupture and fetal hypoxia.[1]
The label warns that Pitocin is not indicated for elective induction of labor because the data are inadequate to weigh benefits and risks.[1]
Adverse events in trials
In the SOARS-B autism trial of intranasal oxytocin, the incidence and severity of adverse events were similar to placebo.[8]
In the intranasal obesity trial there were no serious adverse events and no difference in incidence or severity between groups.[17]
In a frontotemporal dementia trial, headache and upper respiratory tract infection were the most commonly reported adverse events, and none was attributed to oxytocin.[2]
A review of IV dosing at cesarean delivery found initial bolus doses of under 5 IU may reduce nausea, with a risk ratio of 0.26.[5]
How much safety literature exists
A dated PubMed search (2026-10-11) for intranasal oxytocin adverse events or side effects in randomised trials returned 35 records, which this page does not tally by event.
Calculated from evidence file web/src/data/evidence/oxytocin.json; query oxytocin[tiab] AND intranasal[tiab] AND ("adverse events"[tiab] OR "side effects"[tiab]) AND (randomized controlled trial[pt] OR meta-analysis[pt] OR systematic review[pt]); date 2026-10-11; count 35. Formula: count of PubMed records returned by the dated query
The 4 cached trial abstracts on this page report no serious adverse event attributed to intranasal oxytocin, but they were not powered to detect rare events.
Calculated from cached trials 34644471, 34029521, 38815173, 39862881; serious events attributed 0. Formula: count of serious events attributed to oxytocin in the cached trial abstracts = 0
Common questions
What are the side effects of Oxytocin?
The FDA label lists water intoxication, uterine hypertonicity or rupture, anaphylactic reaction (mother) among others. The table on this page gives how often each happened and links each source.
What side effects do people who use Oxytocin report?
In the 23 Reddit threads we read (11 Oct 2026), people most often described flushing or head rush after injection (19 people), headache (7 people), racing heart (4 people). These are unverified personal reports, often from products of unknown purity, and the counts are not rates.
Is Oxytocin safe?
Oxytocin has an FDA-approved label that lists its known risks. That label covers the approved product used as prescribed, not compounded or research-chemical versions.
What are the side effects of oxytocin peptide?
The label's serious ones are water intoxication and uterine hyperactivity; in intranasal trials, adverse events were similar to placebo.[1]
More on Oxytocin
Sources
- 1Pitocin ® (Oxytocin Injection, USP) SyntheticFDA label (Pitocin), DailyMed · current labeldailymed.nlm.nih.govAccessed 2 Oct 2026
- 2Intranasal oxytocin for apathy in people with frontotemporal dementia (FOXY): a multicentre, randomised, double-blind, placebo-controlled, adaptive, crossover, phase 2a/2b superiority trial.The Lancet. Neurology · 2025PMID 39862881Accessed 11 Oct 2026
- 3A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effects of Repeat Doses of Intranasal Oxytocin in Obese AdultsClinicalTrials.gov (U.S. National Library of Medicine) · 2017clinicaltrials.govAccessed 11 Oct 2026
- 4Phase II Study of Oxytocin in Autism to Improve Reciprocal Social BehaviorsClinicalTrials.gov (U.S. National Library of Medicine) · 2013clinicaltrials.govAccessed 11 Oct 2026
- 5Intravenous oxytocin dosing regimens for postpartum hemorrhage prevention following cesarean delivery: a systematic review and meta-analysis.American journal of obstetrics and gynecology · 2021PMID 33957113Accessed 2 Oct 2026
- 6Systematic review and meta-analysis of reported adverse events of long-term intranasal oxytocin treatment for autism spectrum disorder.Psychiatry and clinical neurosciences · 2018PMID 29232031Accessed 11 Oct 2026
- 7Arginine-Vasopressin Dynamics in Relation to Food Intake and 8-Week Intranasal Oxytocin Treatment in Adults With Obesity.The Journal of clinical endocrinology and metabolism · 2025PMID 40314146Accessed 2 Oct 2026
- 8Intranasal Oxytocin in Children and Adolescents with Autism Spectrum Disorder.The New England journal of medicine · 2021PMID 34644471Accessed 2 Oct 2026
- 9Intranasal Oxytocin Improves Lean Muscle Mass and Lowers LDL Cholesterol in Older Adults with Sarcopenic Obesity: A Pilot Randomized Controlled Trial.Journal of the American Medical Directors Association · 2021PMID 34029521Accessed 2 Oct 2026
- 10Oxytocin and autism: a systematic review of randomized controlled trials.Journal of child and adolescent psychopharmacology · 2014PMID 24679173Accessed 11 Oct 2026
- 11Reddit thread in r/Peptides (user reports, unverified)Reddit, via the Arctic Shift archive · 2026reddit.comAccessed 11 Oct 2026
- 12Reddit thread in r/Peptides (user reports, unverified)Reddit, via the Arctic Shift archive · 2025reddit.comAccessed 11 Oct 2026
- 13Reddit thread in r/Peptides (user reports, unverified)Reddit, via the Arctic Shift archive · 2026reddit.comAccessed 11 Oct 2026
- 14Reddit thread in r/Peptides (user reports, unverified)Reddit, via the Arctic Shift archive · 2024reddit.comAccessed 11 Oct 2026
- 15Reddit thread in r/Peptides (user reports, unverified)Reddit, via the Arctic Shift archive · 2024reddit.comAccessed 11 Oct 2026
- 16Reddit thread in r/Peptides (user reports, unverified)Reddit, via the Arctic Shift archive · 2026reddit.comAccessed 11 Oct 2026
- 17Intranasal Oxytocin for Obesity.NEJM evidence · 2024PMID 38815173Accessed 11 Oct 2026
Found an error? Report a correction.